These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 15280398)

  • 1. Genetic pathways to melanoma tumorigenesis.
    Hussein MR
    J Clin Pathol; 2004 Aug; 57(8):797-801. PubMed ID: 15280398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor progression in the human melanocytic system.
    Kath R; Rodeck U; Menssen HD; Mancianti ML; Linnenbach AJ; Elder DE; Herlyn M
    Anticancer Res; 1989; 9(4):865-72. PubMed ID: 2554787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelotypes of primary cutaneous melanoma and benign melanocytic nevi.
    Healy E; Belgaid CE; Takata M; Vahlquist A; Rehman I; Rigby H; Rees JL
    Cancer Res; 1996 Feb; 56(3):589-93. PubMed ID: 8564976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X inactivation, DNA deletion, and microsatellite instability in common acquired melanocytic nevi.
    Indsto JO; Cachia AR; Kefford RF; Mann GJ
    Clin Cancer Res; 2001 Dec; 7(12):4054-9. PubMed ID: 11751501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of microgenomic technology for analysis of alterations in DNA copy number and gene expression in malignant melanoma.
    Trent JM; Bittner M; Zhang J; Wiltshire R; Ray M; Su Y; Gracia E; Meltzer P; De Risi J; Penland L; Brown P
    Clin Exp Immunol; 1997 Jan; 107 Suppl 1():33-40. PubMed ID: 9020934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel genes associated with malignant melanoma but not benign melanocytic lesions.
    Talantov D; Mazumder A; Yu JX; Briggs T; Jiang Y; Backus J; Atkins D; Wang Y
    Clin Cancer Res; 2005 Oct; 11(20):7234-42. PubMed ID: 16243793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular alterations at chromosome 9p21 in melanocytic naevi and melanoma.
    Sini MC; Manca A; Cossu A; Budroni M; Botti G; Ascierto PA; Cremona F; Muggiano A; D'Atri S; Casula M; Baldinu P; Palomba G; Lissia A; Tanda F; Palmieri G
    Br J Dermatol; 2008 Feb; 158(2):243-50. PubMed ID: 18028495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A defined region of loss of heterozygosity at 11q23 in cutaneous malignant melanoma.
    Herbst RA; Larson A; Weiss J; Cavenee WK; Hampton GM; Arden KC
    Cancer Res; 1995 Jun; 55(12):2494-6. PubMed ID: 7780954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concordant loss of heterozygosity of DNA repair gene, hOGG1, in melanoma in situ and atypical melanocytic hyperplasia.
    Pashaei S; Li L; Zhang H; Spencer HJ; Schichman SA; Fan CY; Smoller BR
    J Cutan Pathol; 2008 Jun; 35(6):525-31. PubMed ID: 18312439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of losses of heterozygosity of the candidate tumour suppressor gene DMBT1 in melanoma resection specimens.
    Deichmann M; Mollenhauer J; Helmke B; Thome M; Hartschuh W; Poustka A; Näher H
    Oncology; 2002; 63(2):166-72. PubMed ID: 12239452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic transdifferentiation of normal melanocytes by a metastatic melanoma microenvironment.
    Seftor EA; Brown KM; Chin L; Kirschmann DA; Wheaton WW; Protopopov A; Feng B; Balagurunathan Y; Trent JM; Nickoloff BJ; Seftor RE; Hendrix MJ
    Cancer Res; 2005 Nov; 65(22):10164-9. PubMed ID: 16288000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of melanoma.
    Fountain JW; Bale SJ; Housman DE; Dracopoli NC
    Cancer Surv; 1990; 9(4):645-71. PubMed ID: 2101727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of a t(9;12)(p21;q13) balanced chromosome translocation in combination with integrative genomics analysis identifies C9orf14 as a candidate tumor-suppressor.
    Pujana MA; Ruiz A; Badenas C; Puig-Butille JA; Nadal M; Stark M; Gómez L; Valls J; Solé X; Hernández P; Cerrato C; Madrigal I; de Cid R; Aguilar H; Capellá G; Cal S; James MR; Walker GJ; Malvehy J; Milà M; Hayward NK; Estivill X; Puig S
    Genes Chromosomes Cancer; 2007 Feb; 46(2):155-62. PubMed ID: 17099875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma ex naevo: a study of the associated naevus.
    Bogdan I; Smolle J; Kerl H; Burg G; Böni R
    Melanoma Res; 2003 Apr; 13(2):213-7. PubMed ID: 12690309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression patterns of S100 proteins in melanocytes and melanocytic lesions.
    Petersson S; Shubbar E; Enerbäck L; Enerbäck C
    Melanoma Res; 2009 Aug; 19(4):215-25. PubMed ID: 19521263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PUMA expression is significantly reduced in human cutaneous melanomas.
    Karst AM; Dai DL; Martinka M; Li G
    Oncogene; 2005 Feb; 24(6):1111-6. PubMed ID: 15690057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic alterations in the differential diagnosis of melanocytic diseases].
    Sanz Esponera J
    An R Acad Nac Med (Madr); 2000; 117(4):815-24. PubMed ID: 11382155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular aspects of melanocytic dysplastic nevi.
    Hussein MR; Wood GS
    J Mol Diagn; 2002 May; 4(2):71-80. PubMed ID: 11986397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathogenesis of cutaneous melanocytic neoplasms.
    Ibrahim N; Haluska FG
    Annu Rev Pathol; 2009; 4():551-79. PubMed ID: 19400696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in cutaneous melanoma oncogenesis research.
    Dooley TP
    Oncol Res; 1994; 6(1):1-9. PubMed ID: 7919546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.